Wan , Xuemei, et al. “FCGBP Inhibits the Development of LSCC and Cisplatin Resistance through the PIGR JAK2 STAT3 Pathway”. Radiology and Oncology, vol. 60, no. 1, Mar. 2026, pp. 67-75, https://radioloncol.com/index.php/ro/article/view/4672.